Nuvini Group Set to Report Earnings by End of Sept.
Nuvini Group Limited (NASDAQ: NVNI) shares began Tuesday not much changed from the day before. The leading technology conglomerate in the Latin American SaaS sector today announced that it will release its financial results for the first half of 2025 on Tuesday, September 30, before market open.The Company will also be hosting an Investor Webinar on Tuesday, September 30 at 10:00 a.m. ET during which Nuvini CEO, Pierre Schurmann, will deliver prepared remarks discussing financial results, strategic updates and FY25 outlook. A question-and-answer session will follow the presentation. The company was in the news last week with the announcement that hat Gustavo Usero had been promoted to Chief Operating Officer, effective Monday, September 1.Usero currently serves as Group Operating Director at Nuvini, where he leads operational excellence, financial performance, and strategic execution across the group's portfolio. Headquartered in São Paulo, Brazil, Nuvini is Latin America’s leading private serial acquirer of business to business (B2B) software as a service (SaaS) companies. The Company focuses on acquiring profitable, high-growth SaaS businesses with strong recurring revenue and cash flow generation. By fostering an entrepreneurial environment, Nuvini enables its portfolio companies to scale and maintain leadership within their respective industries. The company’s long-term vision is to buy, retain, and create value through strategic partnerships and operational expertise.NVNI shares were flat to 61 cents.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


